Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Preferred Stock Liabilities (2023 - 2024)

Historic Preferred Stock Liabilities for Inmune Bio (INMB) over the last 2 years, with Q2 2024 value amounting to $799000.0.

  • Inmune Bio's Preferred Stock Liabilities changed N/A to $799000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $799000.0, marking a year-over-year change of. This contributed to the annual value of $799000.0 for FY2023, which is N/A changed from last year.
  • Per Inmune Bio's latest filing, its Preferred Stock Liabilities stood at $799000.0 for Q2 2024.
  • In the past 5 years, Inmune Bio's Preferred Stock Liabilities registered a high of $799000.0 during Q3 2023, and its lowest value of $799000.0 during Q3 2023.